Posted on

is cannabidiol cbd legal

There is an exception to section 201(ff)(3)(B) if the substance was “marketed as” a dietary supplement or as a conventional food before the drug was approved or before the new drug investigations were authorized, as applicable. However, based on available evidence, FDA has concluded that this is not the case for THC or CBD.

16. What is FDA’s role when it comes to the investigation of cannabis and cannabis-derived products for medical use?

Regulatory Resources

FDA is not aware of any evidence that would call into question its current conclusions that THC and CBD products are excluded from the dietary supplement definition under section 201(ff)(3)(B) of the FD&C Act. Interested parties may present the agency with any evidence that they think has bearing on this issue. Our continuing review of information that has been submitted thus far has not caused us to change our conclusions.

A. Expanded access is a potential pathway for a patient with a serious or life-threatening disease or condition to try an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when there are no comparable or satisfactory therapies available. Manufacturers may be able to make investigational drugs available to individual patients in certain circumstances through expanded access, as described in the FD&C Act and implementing regulations.

In addition, under 21 CFR 530.20, extralabel use of an approved human drug in a food-producing animal is not permitted if an animal drug approved for use in food-producing animals can be used in an extralabel manner for the use. In addition, under 21 CFR 530.20(b)(2), if scientific information on the human food safety aspect of the use of the approved human drug in food-producing animals is not available, the veterinarian must take appropriate measures to ensure that the animal and its food products will not enter the human food supply.
For more information on extralabel use of FDA approved drugs in animals, see Extralabel Use of FDA Approved Drugs In Animals.

If you are interested in learning more about CBD and the legality of CBD products, Medical Marijuana, Inc. has put together tons of useful resources to help you. Visit our CBD Oil Education page to learn more about a range of topics, including more information on CBD, its effects, and how CBD products can benefit you.

CBD is legal federally in the United States, but what about the rest of the world? CBD products are also legal internationally in many countries around the world. However, the level of legality and classification of CBD may vary. In some countries, they are listed as prescription medications. In others, CBD oil is sold as consumer products, just as they are here in the U.S.

Due to legislation passed at the end of 2018, hemp and its derivative products are legal in the U.S. That means that on a federal level hemp CBD products are currently legal as well.

Is CBD Legal Outside of the United States?

Since CBD products are now federally legal, you can safely take them through TSA checkpoints when flying without any fear of getting in trouble. As long as travelers have CBD products that adhere to the regulations outlined in the 2018 Farm Bill, the TSA will permit them on an airplane.

Your state’s laws regarding CBD and hemp may affect the types of CBD products that are available to you when purchasing online or in stores. Before buying CBD or traveling with it to other states, we recommend that you become aware of any local laws that may affect you.

Is CBD legal where I live? While hemp-derived CBD products are legal under federal law in the United States, it is important to keep in mind that individual state laws are dynamic and fluid. Individual states may enact their own laws regarding the legality and distribution of hemp-derived CBD.

With the removal of hemp from the list of controlled substances, regulation of hemp and hemp-derived CBD now falls on the U.S. Food and Drug Administration (FDA). The agency is working to create a framework that would clearly regulate the creation, sales, and marketing of CBD products for consumers.

The Georgia Department of Public Health issues Low THC Oil Registry Cards ($25 fee) to qualifying patients with one of 16 conditions: cancer, ALS, seizure disorders, multiple sclerosis, Crohn’s disease, mitochondrial disease, Parkinson’s disease, sickle cell disease, Tourette’s syndrome, autism spectrum disorder, when (a) patient is 18 years of age or more, epidermolysis bullosa, Alzheimer’s disease, AIDS, peripheral neuropathy, hospice program patients, intractable pain, and PTSD.

According to the North Carolina Department of Health and Human Services (DHHS), “hemp extract must be composed of less than nine-tenths of one percent (0.9%) tetrahydrocannabinol (THC) by weight, at least five percent (5%) cannabidiol (CBD) by weight and may contain no other psychoactive substances.” By law, patients are allowed to use and possess CBD but it remains illegal to cultivate or produce hemp extract in the state. People in possession of the DHHS Caregiver Registration letter are allowed to carry hemp extract outside their homes.

On June 2, 2014, South Carolina Governor Nikki Haley signed S 1035 into law. “Julian’s Law” pertains to people who obtain a written certification signed by a physician “stating that the patient has been diagnosed with Lennox-Gastaut Syndrome, Dravet Syndrome, also known as ‘severe myoclonic epilepsy of infancy’, or any other severe form of epilepsy that is not adequately treated by traditional medical therapies and the physician’s conclusion that the patient might benefit from the medical use of cannabidiol.” Those patients may use CBD oil that is less than 0.9% THC and more than 15% cannabidiol, which is to be provided by the Medical University of South Carolina in a study to determine the effects of CBD on controlling seizures.

On May 4, 2016, Gov. Bentley signed HB 61 into law. Known as Leni’s Law, the bill provides an affirmative defense for possession of CBD oil “for specified debilitating conditions that produce seizures.”

On Apr. 17, 2017, Gov. Walker signed SB 10 into law, which replaced “seizure disorder” with “medical condition,” broadening the original bill.